Tangent90 Ltd, a leading provider of digital solutions to help pharmaceutical companies improve their engagement with healthcare professionals (HCPs), has entered into a strategic collaboration with NEJM Group publications (New England Journal of Medicine, NEJM Evidence, NEJM Catalyst, NEJM Journal Watch).
The New England Journal of Medicine (NEJM) is recognised as the world's leading medical journal. With its long history of publishing trusted, impactful, peer-reviewed original content, NEJM will use Tangent90's Trustrack links to support digital rights management and seamless access to content for its pharmaceutical clients looking to reach HCPs. Trustrack links deliver an optimized HCP experience across all channels and provide insights into content utilization, which helps support the identification of 'next best action' with 'next best scientific content' to deliver the most appropriate content to the HCP.
In recognition of HCP learning preferences and time constraints, NEJM has expanded its Original Research articles by offering both textual summaries (Research Summaries) and video summaries (QuickTake Videos). These formats support the busy, practising clinician and map particularly well in digital engagement efforts. By working with Tangent90 to make these formats available to its clients via Trustrack, NEJM is expanding opportunities to engage physicians with its high-quality content.
Additionally, Tangent90 collaborated with NEJM to extend the Tangent90 Resource Centre platform to include NEJM Group content, tagged in a manner that will expose all appropriate content, beyond the traditional Original Research article.
Click here to read the original press release.
